Shareholders of Morrisville-based Furiex Pharmaceuticals (Nasdaq: FURX) have officially OK’d Forest Laboratories $1.4-billion buy of the company.
By a vote of 8,636,934 to 13,949, stockholders approved the deal.
The merger, announced in April, also snagged clearance from the Ukrainian Antimonopoly Committee – one of the final hurdles before the deal can close. Technically, Furiex will be acquired by Irish pharma Actavis (NYSE: ACT) which, as of Tuesday, has officially closed on its own acquisition…